Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Elite Pharmaceuticals (ELTP) Risk Analysis

Public companies are required to disclose risks that can affect the business and impact the stock. These disclosures are known as “Risk Factors”. Companies disclose these risks in their yearly (Form 10-K), quarterly earnings (Form 10-Q), or “foreign private issuer” reports (Form 20-F). Risk factors show the challenges a company faces. Investors can consider the worst-case scenarios before making an investment. TipRanks’ Risk Analysis categorizes risks based on proprietary classification algorithms and machine learning. Elite Pharmaceuticals disclosed 40 risk factors in its most recent earnings report. Elite Pharmaceuticals reported the most risks in the “Finance & Corporate” category.

Risk Overview Q4, 2025

Source: the company's latest filing for the period ended Dec 31, 2025, filed Feb 17, 2026

Risk Distribution
40Risks
Sector Avg.Finance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Risk Change Over Time

Elite Pharmaceuticals disclosed risks per quarterNo. of Risks384042444648Q3Q4Q2Q3Q4Q12025Q2Q3Q4Showing: Q1, 2025
Risks removedRisks addedRisks changedElite Pharmaceuticals Risk Factors
New Risk (12)Risk Removed (19)
  • Share Price & Shareholder Rights - Risk 1
    Dilution from issuance of shares to Directors, Officers, Employees, Consultants or upon exercise of warrants and options or the perception that dilution may occur could cause the price per share of common stock to fall fall.

    The issuance of additional shares through stock options, warrants, and other equity awards may dilute the ownership interest of existing shareholders. This dilution, or even the expectation of it, can depress the market price of our common stock and adversely affect investor confidence.

  • Accounting & Financial Operations - Risk 2
    Our reporting and payment obligations under the Medicaid rebate program and other governmental purchasing and rebate programs are complex and may involve subjective decisions. Any determination that we have failed to comply with those obligations could subject us to penalties and sanctions which could have a material adverse effect on our business review.

    We establish liabilities for sales allowances including discounts, returns, chargebacks, and rebates under Medicaid and other governmental programs. The methodologies used involve significant judgment. If our estimates prove inaccurate or if regulatory reviews determine noncompliance, we could face penalties or increased financial burdens that may materially affect our profitability.

Read and Evaluate the RiskReserved for Ultimate MembersUpgrade
Tech & Innovation (1)
Legal & Regulatory (2)
Production (1)
Ability to Sell (1)

Risk Highlights Q4, 2025

Main Risk Category
Finance & Corporate
With 17 Risks
Number of Disclosed Risks
40
No changes from last report
S&P 500 Average: 32
Recent Changes
0Risks added
0Risks removed
0Risks changed
Since Dec 2025
Number of Risk Changed
0
No changes from last report
S&P 500 Average: 1

Risk Word Cloud

our ability to fund operations is uncertain and we may require additional financing to meet objectives.our ability to fund operationswhile we currently qualify as a smaller reporting company under sec regulations, we cannot be certain, if we take advantage of the reduced disclosure requirements applicable to these companies, that we will not make our stock less attractive to investors. once we lose smaller reporting company status, the costs and demands placed upon our management are expected to increase.lose smaller reporting company statusour operations could be disrupted by failure of our information systems or cyber-attacks.failure of our information systemsdelays in generic product development may result in failure to achieve adequate return on investment.failure to achieve adequate returnwe have no plans to pay regular dividends or conduct share purchases.plans to pay regular dividendsour ability to protect intellectual property rights and successfully defend against third-party allegations of ip infringement is vital to our business and uncertain.third-party allegations of ip infringementinvestigations and litigation concerning the calculation of average wholesale prices may adversely affect our business.calculation of average wholesale pricesdilution from issuance of shares to directors, officers, employees, consultants or upon exercise of warrants and options or the perception that dilution may occur could cause the price per share of common stock to fall.issuance of shares to directorswe are subject to various fraud and abuse laws which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits and future earnings.expose us to criminal sanctionsissuance of shares of common or preferred stock could make achieving a change of control more difficult.issuance of shares of common

Risk Factors Full Breakdown - Total Risks 40

Share Price & Shareholder Rights7 | 17.5%
  • Share Price & Shareholder Rights - Risk 1
    Issuance of shares of common or preferred stock could make achieving a change of control more difficult.

    The issuance of additional equity, including convertible instruments or preferred stock, may be used to deter hostile takeovers. However, such actions can also complicate potential corporate transactions and may reduce the attractiveness of our stock to potential investors.

  • Share Price & Shareholder Rights - Risk 2
    Capital raises through sales of securities may cause substantial dilution to existing shareholders.

    If we raise additional capital by issuing new shares, existing shareholders could experience significant dilution in their ownership percentage. This potential dilution may lead to a decline in the value of their investment and could negatively impact the market price of our common stock.

  • Share Price & Shareholder Rights - Risk 3
    Our stock price has been volatile.

    Our common stock has experienced significant price fluctuations due to various factors including market conditions, regulatory developments, litigation, and industry-specific risks. This volatility can negatively affect investor confidence and the overall perceived value of our shares.

  • Share Price & Shareholder Rights - Risk 4
    Shareholder activism could negatively affect us.

    Shareholder activism, including efforts to alter corporate governance, strategic direction, or management, may force management to divert attention, incur significant legal expenses, or implement changes that are not in the best interests of the company, thereby adversely impacting our business operations and share price.

  • Share Price & Shareholder Rights - Risk 5
    Our common stock is a penny stock, quoted on the OTC bulletin board, with rules in place that could limit trading and liquidity of our shares, increased transaction costs that could adversely affect our price per share.

    Being classified as a low-priced or penny stock subjects our common stock to additional regulatory requirements and trading restrictions that can limit liquidity, increase transaction costs, and contribute to higher price volatility. These factors may make it more difficult for investors to trade our shares at favorable prices.

  • Share Price & Shareholder Rights - Risk 6
    Dilution from issuance of shares to Directors, Officers, Employees, Consultants or upon exercise of warrants and options or the perception that dilution may occur could cause the price per share of common stock to fall.

    The issuance of additional shares through stock options, warrants, and other equity awards may dilute the ownership interest of existing shareholders. This dilution, or even the expectation of it, can depress the market price of our common stock and adversely affect investor confidence.

  • Share Price & Shareholder Rights - Risk 7
    While we currently qualify as a smaller reporting company under SEC regulations, we cannot be certain, if we take advantage of the reduced disclosure requirements applicable to these companies, that we will not make our stock less attractive to investors. Once we lose smaller reporting company status, the costs and demands placed upon our management are expected to increase.

    The SEC’s rules exempt smaller reporting companies from various disclosure requirements, including the omission of an auditor’s attestation on internal control over financial reporting. However, if our public float grows or if we lose smaller reporting company status, increased reporting obligations and related costs may arise, potentially making our stock less attractive to investors.

Accounting & Financial Operations6 | 15.0%
Debt & Financing4 | 10.0%

See a full breakdown of risk according to category and subcategory. The list starts with the category with the most risk. Click on subcategories to read relevant extracts from the most recent report.

FAQ

What are “Risk Factors”?
Risk factors are any situations or occurrences that could make investing in a company risky. The Securities and Exchange Commission (SEC) requires that publicly traded companies disclose their most significant risk factors. This is so that potential investors can consider any risks before they make an investment. They also offer companies protection, as a company can use risk factors as liability protection. This could happen if a company underperforms and investors take legal action as a result. It is worth noting that smaller companies, that is those with a public float of under $75 million on the last business day, do not have to include risk factors in their 10-K and 10-Q forms, although some may choose to do so.
How do companies disclose their risk factors?
Publicly traded companies initially disclose their risk factors to the SEC through their S-1 filings as part of the IPO process. Additionally, companies must provide a complete list of risk factors in their Annual Reports (Form 10-K) or (Form 20-F) for “foreign private issuers”. Quarterly Reports also include a section on risk factors (Form 10-Q) where companies are only required to update any changes since the previous report. According to the SEC, risk factors should be reported concisely, logically and in “plain English” so investors can understand them.
How can I use TipRanks risk factors in my stock research?
Use the Risk Factors tab to get data about the risk factors of any company in which you are considering investing. You can easily see the most significant risks a company is facing. Additionally, you can find out which risk factors a company has added, removed or adjusted since its previous disclosure. You can also see how a company’s risk factors compare to others in its sector. Without reading company reports or participating in conference calls, you would most likely not have access to this sort of information, which is usually not included in press releases or other public announcements. A simplified analysis of risk factors is unique to TipRanks.
What are all the risk factor categories?
TipRanks has identified 6 major categories of risk factors and a number of subcategories for each. You can see how these categories are broken down in the list below. 1. Financial & Corporate Accounting & Financial Operations - risks related to accounting loss, value of intangible assets, financial statements, value of intangible assets, financial reporting, estimates, guidance, company profitability, dividends, fluctuating results. Share Price & Shareholder Rights – risks related to things that impact share prices and the rights of shareholders, including analyst ratings, major shareholder activity, trade volatility, liquidity of shares, anti-takeover provisions, international listing, dual listing. Debt & Financing – risks related to debt, funding, financing and interest rates, financial investments. Corporate Activity and Growth – risks related to restructuring, M&As, joint ventures, execution of corporate strategy, strategic alliances. 2. Legal & Regulatory Litigation and Legal Liabilities – risks related to litigation/ lawsuits against the company. Regulation – risks related to compliance, GDPR, and new legislation. Environmental / Social – risks related to environmental regulation and to data privacy. Taxation & Government Incentives – risks related to taxation and changes in government incentives. 3. Production Costs – risks related to costs of production including commodity prices, future contracts, inventory. Supply Chain – risks related to the company’s suppliers. Manufacturing – risks related to the company’s manufacturing process including product quality and product recalls. Human Capital – risks related to recruitment, training and retention of key employees, employee relationships & unions labor disputes, pension, and post retirement benefits, medical, health and welfare benefits, employee misconduct, employee litigation. 4. Technology & Innovation Innovation / R&D – risks related to innovation and new product development. Technology – risks related to the company’s reliance on technology. Cyber Security – risks related to securing the company’s digital assets and from cyber attacks. Trade Secrets & Patents – risks related to the company’s ability to protect its intellectual property and to infringement claims against the company as well as piracy and unlicensed copying. 5. Ability to Sell Demand – risks related to the demand of the company’s goods and services including seasonality, reliance on key customers. Competition – risks related to the company’s competition including substitutes. Sales & Marketing – risks related to sales, marketing, and distribution channels, pricing, and market penetration. Brand & Reputation – risks related to the company’s brand and reputation. 6. Macro & Political Economy & Political Environment – risks related to changes in economic and political conditions. Natural and Human Disruptions – risks related to catastrophes, floods, storms, terror, earthquakes, coronavirus pandemic/COVID-19. International Operations – risks related to the global nature of the company. Capital Markets – risks related to exchange rates and trade, cryptocurrency.